BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1725 related articles for article (PubMed ID: 15205364)

  • 21. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
    Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
    Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis.
    Desjardins F; Lobysheva I; Pelat M; Gallez B; Feron O; Dessy C; Balligand JL
    Cardiovasc Res; 2008 Aug; 79(3):527-36. PubMed ID: 18349137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression.
    Bucci M; Roviezzo F; Brancaleone V; Lin MI; Di Lorenzo A; Cicala C; Pinto A; Sessa WC; Farneti S; Fiorucci S; Cirino G
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):721-6. PubMed ID: 14962949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice.
    Qi X; Okamoto Y; Murakawa T; Wang F; Oyama O; Ohkawa R; Yoshioka K; Du W; Sugimoto N; Yatomi Y; Takuwa N; Takuwa Y
    Eur J Pharmacol; 2010 May; 634(1-3):121-31. PubMed ID: 20206620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of pulsatile shear stress on signaling mechanisms controlling nitric oxide production, endothelial nitric oxide synthase phosphorylation, and expression in ovine fetoplacental artery endothelial cells.
    Li Y; Zheng J; Bird IM; Magness RR
    Endothelium; 2005; 12(1-2):21-39. PubMed ID: 16036314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells.
    Kroll J; Waltenberger J
    Biochem Biophys Res Commun; 1999 Nov; 265(3):636-9. PubMed ID: 10600473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
    Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells.
    Józkowicz A; Pankiewicz J; Dulak J; Partyka L; Wybrańska I; Huk I; Dembińska-Kieć A
    Acta Biochim Pol; 1999; 46(3):703-15. PubMed ID: 10698278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the cardiac angiogenic response to exogenous vascular endothelial growth factor.
    Voisine P; Bianchi C; Ruel M; Malik T; Rosinberg A; Feng J; Khan TA; Xu SH; Sandmeyer J; Laham RJ; Sellke FW
    Surgery; 2004 Aug; 136(2):407-15. PubMed ID: 15300208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
    Gao L; Yu DM
    Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
    Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of G(i/o)-Src kinase-PI3K/Akt pathway and caveolin-1 in β₂-adrenoceptor coupling to endothelial NO synthase in mouse pulmonary artery.
    Banquet S; Delannoy E; Agouni A; Dessy C; Lacomme S; Hubert F; Richard V; Muller B; Leblais V
    Cell Signal; 2011 Jul; 23(7):1136-43. PubMed ID: 21385608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central role of calcium-dependent tyrosine kinase PYK2 in endothelial nitric oxide synthase-mediated angiogenic response and vascular function.
    Matsui A; Okigaki M; Amano K; Adachi Y; Jin D; Takai S; Yamashita T; Kawashima S; Kurihara T; Miyazaki M; Tateishi K; Matsunaga S; Katsume A; Honshou S; Takahashi T; Matoba S; Kusaba T; Tatsumi T; Matsubara H
    Circulation; 2007 Aug; 116(9):1041-51. PubMed ID: 17698736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model.
    Urano T; Ito Y; Akao M; Sawa T; Miyata K; Tabata M; Morisada T; Hato T; Yano M; Kadomatsu T; Yasunaga K; Shibata R; Murohara T; Akaike T; Tanihara H; Suda T; Oike Y
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):827-34. PubMed ID: 18258819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aortic eNOS expression and phosphorylation in Apo-E knockout mice: differing effects of rapamycin and simvastatin.
    Naoum JJ; Zhang S; Woodside KJ; Song W; Guo Q; Belalcazar LM; Hunter GC
    Surgery; 2004 Aug; 136(2):323-8. PubMed ID: 15300198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caveolin-1 interacts and cooperates with the transforming growth factor-beta type I receptor ALK1 in endothelial caveolae.
    Santibanez JF; Blanco FJ; Garrido-Martin EM; Sanz-Rodriguez F; del Pozo MA; Bernabeu C
    Cardiovasc Res; 2008 Mar; 77(4):791-9. PubMed ID: 18065769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.
    Razani B; Engelman JA; Wang XB; Schubert W; Zhang XL; Marks CB; Macaluso F; Russell RG; Li M; Pestell RG; Di Vizio D; Hou H; Kneitz B; Lagaud G; Christ GJ; Edelmann W; Lisanti MP
    J Biol Chem; 2001 Oct; 276(41):38121-38. PubMed ID: 11457855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions.
    Feron O; Michel JB; Sase K; Michel T
    Biochemistry; 1998 Jan; 37(1):193-200. PubMed ID: 9425039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 87.